Completed PHASE2 INTERVENTIONAL NCT00108446

Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome

Sponsor: US Department of Veterans Affairs

Interventions dextromethorphan fentanyl lidocaine naloxone

Updated 6 times since 2017 Last updated: Jan 20, 2009 Started: Oct 31, 2003 Completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00108446, this PHASE2 trial focuses on Irritable Bowel Syndrome and remains completed. Sponsored by US Department of Veterans Affairs, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Aug 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Aug 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

US Department of Veterans Affairs

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States